close

Enter

Log in using OpenID

MicroRNA Market Share

embed
The global microRNA market size is expected to expand at a steady CAGR over the forecast period.
Your CatalystTo a Lucrative Business
MicroRNA Market Size, Application Analysis, Regional Outlook,
Competitive Strategies and Forecasts, 2015 to 2025 | Hexa
Research
“Increasing popularity of cloud-based security
messaging is one of the primary factors escalating
the growth of the Messaging Security Market.”
The Global MicroRNA Market size is expected to expand at a steady CAGR over the forecast period.
MicroRNA is a small non-coding RNA that plays a significant role in plants and animals by targeting specific
mRNAs for degradation or translation repression. Growing number of biotech and pharmaceutical companies
involved in research and development (R&D) activities such as molecular diagnostics and therapeutics is
expected to drive market growth. Ample opportunities for applications in virology, cardiovascular,
endocrinology, genetic disease, and plant science are anticipated to further fuel expansion in near future.
One of the major factors contributing to market growth is the provision of large scale public and private
funding. Government investment and increasing technological developments are anticipated to further drive
growth. High prevalence of diseases is expected to encourage pharmaceutical and biotech companies to
engage in R&D in different disease classes. Increasing occurrence of cardiovascular and cancer is expected to
drive the market at a steady pace. According to WHO, about 14 million cancer cases were registered in 2012
and the number is estimated to grow at an alarming rate in the years to come.
Recent innovations and diverse applications are anticipated to contribute to growth of the market for
microRNA over the forecast period. The technology is used as a biomarker for cancer diagnosis and
treatment. Increasing investments in R&D initiatives to develop new diagnostic tests and therapeutics is also
expected to fuel product demand. Increased target selectivity and specificity of RNAi therapeutics, along with
adoption of virtual drug development models enables companies to minimize costs associated with research
and production.
Browse Details of Report @ https://www.hexaresearch.com/research-report/microrna-market
Follow Us:
Your CatalystTo a Lucrative Business
Shift from platform technologies to application-specific products is expected to bode well for market
expansion. Developing drugs or biologics through virtual drug development platforms offers significant
advantages over traditional models such as minimizing risks and overhead costs associated with conventional
technologies. miRNAs play a major role in various biological processes including developmental timing, cell
proliferation, apoptosis, stem cell maintenance, differentiation, signaling pathways, and pathogenesis such as
carcinogenesis. This factor is anticipated to boost growth of the market over the forecast period.
On the other hand, stringent regulations and high investment cost are expected to be the major restraints for
the global market. High costs associated with equipment used in detecting miRNA along with ex tensive and
time-consuming testing methods, subsequently contributes in increasing overall research value. High failure
rate coupled with the lack of skilled professionals with superior industry experience may hamper market
growth.
However, increasing collaborations and mergers among biotechnology firms and government research
agencies are expected to positively influence market expansion. New research and patents related to
nanomaterial conjugation with microRNA molecules are anticipated to create immense potential for future
developments particularly in nanotherapeutics and nanomedicine.
Research tools, diagnostic technologies, and reagents are the major therapeutics in the global market.
Research tool was a significant therapeutic section in the past. Diagnostic technologies are anticipated
witnessing substantial growth in the forthcoming years owing to high demand for cancer treatment and
clinical experiments. Enabled microRNA technologies comprises purification, labeling, linear amplification,
microarrays, art-PCR, and inhibition. Enabled technologies, on the other hand, include interference (RNAi)
and antisense technology.
Enabled technologies are projected to account for the largest share in near future owing to significant use in
therapeutics. RNAi technology is expected to emerge dominant due to rising investments in drug
development. RNA therapeutics find applications in chronic conditions including kidney, cardiovascular,
oncology, metabolic, and cardiovascular diseases. Shifting focus on pipeline research for infectious and
oncology diseases attributed to their high occurrence and failure rate of existing treatment processes can
further propel growth.
Medical diagnostics, research, and therapeutics are the major end uses of microRNA technology. Resea rch
and medical diagnostics sectors are expected to enhance effectiveness of RNA drug technology and
therapies. This factor is anticipated to further boost market growth in the forthcoming years.
Developed regions like North America and Europe are dominant the global demand for microRNA due to
presence of advanced life science research infrastructure and R&D organizations. In North America, U.S.
represents largest market followed by Canada. France, Germany, Italy, U.K., and Spain are some of the major
contributors in Europe. Asia Pacific is projected to witness significant CAGR over the forecast period owing to
Follow Us:
Your CatalystTo a Lucrative Business
increased investment by major companies. Also, flexible regulations are expected to steer regional market
growth. India and China are projected to witness fastest growth in near future.
Key players operating in the global microRNA market include Alnylam Pharmaceuticals, Inc.; Affymetrix;
Santaris Pharma; AstraZeneca Pharmaceuticals LP; Exiqon; and Biogen Idec, Inc. Other industry participants
include Pfizer Inc., Eli Lilly and Co., CBC Biomarker Center GmbH, GlaxoSmithKline, F. Hoffman -La Roche,
Merck & Co, and Novartis AG. Recent innovations have enhanced investments in medical sector for
conducting clinical tests and developing new drugs. Ongoing R&D initiatives coupled with favorable
government initiatives, and business collaborations are expected to present growth opportunities to market
players.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcareindustry
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website - http://www.hexaresearch.com
Follow Us:
Your CatalystTo a Lucrative Business
Follow Us:
Author
sara01.james
sara01.james530   documents Email
Document
Category
Health and Medicine
Views
19
File Size
1 006 KB
Tags
microRNA market share, market, Microrna Market, Microrna Market size
1/--pages
Report inappropriate content